Your English writing platform
Discover LudwigSuggestions(2)
Exact(1)
Using the MammaPrint microarray test in the clinical setting will provide more accurate information on recurrence risk as compared to conventional clinical criteria and will thus improve the guidance for the requirement of adjuvant therapy for young women diagnosed with breast cancer.
Similar(59)
Although gene expression profiling using microarray technology is widely used in research environments, adoption of microarray testing in clinical laboratories is currently limited.
The use of microarray testing in individuals with ASD and MCA has significantly increased the rate of identification of an underlying genetic etiology.
In all validation steps, only 5 genes amplified by qPCR were analyzed in the microarray test datasets and no further gene selection was used in the cross-validation loops.
42 The microarray testing can, in many cases, replace conventional karyotyping.
Additional genetic factors, such as other CNVs, may be identified via microarray testing, but in many cases, the other influences on the phenotype remain unknown.
We also tested the immunoreactivity of PTP4A3/PRL-3 in the same microarray test samples.
In a DNA microarray test, TNF- α and IL-10 were not selected (Table 3), although the levels of them in BALF were clearly detected in RSV-infected offspring (Table 2).
Differentially expressed genes were identified using the Significance Analysis of Microarray (SAM) test in the MultiExperiment Viewer (MeV, v4.8), a part of the TM4 Microarray Software Suite (Dana-Farber Cancer Institute, Boston, MA, USA).
A description of all the pools required for microarray testing is presented in Table 3.
Microarray testing was done in two batches but we found no evidence for a batch effect in our analyses.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com